Sputnik V

 - Sakshi Post
Jul 13, 2021
The single-dose variant of Russia’s Sputnik-V vaccine has shown 94 per cent efficacy among Covid-19 patients. Scientists said that there is no evident benefit of using a second dose in previously...
 - Sakshi Post
Jun 11, 2021
The Indian government started the vaccination drive with Covishield and Covaxin in January this year. However, later it approved Russia's Sputnik-V vaccine for only emergency use.
 - Sakshi Post
Jun 05, 2021
The Serum Institute of India has got permission from the DCGI to make Russia's Covid-19 vaccine Sputnik-V. Adar Poonawalla's company will first test, analyse and then manufacture the vaccine at Pune.
 - Sakshi Post
Jun 03, 2021
The Serum Institute of India (SII) has put up an application to the Drug Controller General of India (DCGI) seeking permission to manufacture Sputnik-V vaccine in the country, sources said.
 - Sakshi Post
May 18, 2021
Drug firm Shilpa Medicare and Dr Reddy's Laboratories entered into an agreement under which they will together be manufacturing the Sputnik V vaccine.
 - Sakshi Post
May 17, 2021
The vaccination drive for Russia's Covid-19 vaccine Sputnik V was launched in Telangana and Andhra Pradesh. The first dose of Sputnik V was given to Dr Reddy's Laboratories Ltd employee, Ashok.
 - Sakshi Post
May 17, 2021
Sputnik V COVID vaccine has been launched in Hyderabad today. The first dose was administered to Ashok, one of Dr. Reddy's employee.
 - Sakshi Post
Apr 30, 2021
The Telangana government is in talks with Bharat Biotech and Dr Reddy’s Laboratories (DRL) for procuring Covid-19 vaccines in the state to ensure all those above 18 get the jab.
 - Sakshi Post
Apr 27, 2021
Talking about the use of the vaccine, Sputnik V developer Gamaleya Research Centre shared that the decision regarding wait time between each vaccine dose is up to India. They can make a call and go...
 - Sakshi Post
Sep 16, 2020
MOSCOW/HYDERABAD: The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr Reddy’s Laboratories Ltd, a global pharmaceuti
 - Sakshi Post
Aug 19, 2020
Kirill Dmitriev the CEO of the Russian Direct Investment Fund which is funding the vaccine that may cure COVID-19 said that "Moscow is keen to manufacture coronavirus
Back to Top